Komori
M&A and Subsidiary Changes4102Maruo Calcium Co.,Ltd.Materials and Chemicals

Notice Concerning Tendering Shares in the Tender Offer and Recognition of Extraordinary Income (Gain on Sale of Investment Securities)

All 100,000 shares held in MARUWN CORPORATION were tendered and sold in the tender offer by SENKO Group Holdings Co.,Ltd. As a result, a ¥75 million gain on the sale of investment securities was recorded as an extraordinary gain in the fourth quarter of the fiscal year ending March 2026.

Worth reading
63In focus
Scored from 4 of 5 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
75
¥ million
Wording
Definitive
How definitive the wording is.

This transaction

This tender offer
CounterpartySENKO Group Holdings Co.,Ltd.
Disclosing companyMaruo Calcium Co.,Ltd.
MARUWN CORPORATIONSubject of this transactionNumber of shares acquired 100,000 shares (shares tendered; number of voting rights: Not disclosed)
TimelineThe spacing between the points is proportional to the actual number of days.
Consideration and expenses
Type of ConsiderationCash (¥949 per common share)
Tender offer price¥949 per common share
Tender offer period26 January 2026 to 5 March 2026
Amount of extraordinary income (loss)¥75 million (gain on sale of investment securities, fourth quarter of the fiscal year ending March 2026)
Impact on Business Performance

A ¥75 million extraordinary gain was recorded as a gain on the sale of investment securities in the fourth quarter of the fiscal year ending March 2026

This transaction
ItemDetails
Transaction nameThis tender offer
Counterparty nameSENKO Group Holdings Co.,Ltd.
Name of the Subject CompanyMARUWN CORPORATION
Type of ConsiderationCash (¥949 per common share)
Tender offer price¥949 per common share
Tender offer period26 January 2026 to 5 March 2026
Number of shares acquired100,000 shares (shares tendered; number of voting rights: Not disclosed)
Amount of extraordinary income (loss)¥75 million (gain on sale of investment securities, fourth quarter of the fiscal year ending March 2026)
Impact on Business PerformanceA ¥75 million extraordinary gain was recorded as a gain on the sale of investment securities in the fourth quarter of the fiscal year ending March 2026
Date of board resolution28 January 2026
Execution Date / Effective Date12 March 2026 (settlement commencement date). All shares held in MARUWN CORPORATION have been sold
Items this document does not state (21)
Business Description of the Subject CompanyLocation of the Subject CompanyCapital Stock of the Subject CompanyDate of Establishment of the Subject CompanyNet Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceMerger ratio/share exchange ratioMinimum number of shares to be purchasedVoting rights ownership percentageFunding arrangementsGoodwill amountContract DateValuation methodologyIndependent valuation institutionSpecial CommitteeConditions Precedent to ExecutionManagement structure after acquisition

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The tender offer was supported by the board of directors of MARUWN CORPORATION, and it was determined that the terms of the tender offer would contribute to enhancing the Company's corporate value.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Tendering Shares in the Tender Offer and Recognition of Extraordinary Income (Gain on Sale of Investment Securities) | Maruo Calcium Co.,Ltd. (4102) timely disclosure | Komori